Corteva, Inc. $CTVA Shares Sold by Inceptionr LLC

Inceptionr LLC cut its position in shares of Corteva, Inc. (NYSE:CTVA) by 72.0% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 6,243 shares of the company’s stock after selling 16,026 shares during the period. Inceptionr LLC’s holdings in Corteva were worth $422,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Empirical Finance LLC increased its position in shares of Corteva by 0.6% in the second quarter. Empirical Finance LLC now owns 24,935 shares of the company’s stock valued at $1,858,000 after buying an additional 153 shares in the last quarter. Fox Run Management L.L.C. boosted its position in shares of Corteva by 5.1% in the 3rd quarter. Fox Run Management L.L.C. now owns 3,361 shares of the company’s stock worth $227,000 after buying an additional 164 shares in the last quarter. IFG Advisory LLC grew its stake in Corteva by 1.7% in the 3rd quarter. IFG Advisory LLC now owns 9,764 shares of the company’s stock valued at $660,000 after acquiring an additional 166 shares during the last quarter. United Community Bank grew its stake in Corteva by 10.5% in the 3rd quarter. United Community Bank now owns 1,849 shares of the company’s stock valued at $125,000 after acquiring an additional 176 shares during the last quarter. Finally, Binnacle Investments Inc increased its holdings in Corteva by 54.7% during the 2nd quarter. Binnacle Investments Inc now owns 512 shares of the company’s stock valued at $38,000 after acquiring an additional 181 shares in the last quarter. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Corteva Stock Performance

Shares of NYSE CTVA opened at $78.65 on Thursday. The company has a market cap of $52.89 billion, a PE ratio of 49.78, a price-to-earnings-growth ratio of 2.61 and a beta of 0.72. Corteva, Inc. has a 12 month low of $53.40 and a 12 month high of $80.90. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. The company has a 50-day simple moving average of $73.63 and a 200-day simple moving average of $69.13.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.22. The business had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The company’s revenue was down 1.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be given a $0.18 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s payout ratio is currently 45.57%.

Wall Street Analysts Forecast Growth

CTVA has been the subject of a number of research reports. Wolfe Research lifted their target price on shares of Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Citigroup raised their price objective on shares of Corteva from $74.00 to $80.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. Wall Street Zen downgraded Corteva from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. UBS Group lowered Corteva from a “buy” rating to a “hold” rating in a research note on Monday, February 9th. Finally, Oppenheimer set a $86.00 target price on Corteva in a report on Thursday, February 5th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat.com, Corteva has a consensus rating of “Moderate Buy” and a consensus price target of $82.90.

Insider Buying and Selling

In related news, insider Brian Titus sold 8,311 shares of the stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the transaction, the insider directly owned 8,090 shares in the company, valued at approximately $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.14% of the company’s stock.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.